ABVE Strangle Strategy
ABVE (Above Food Ingredients Inc. Common Stock), in the Consumer Defensive sector, (Packaged Foods industry), listed on NASDAQ.
Above Food Ingredients Inc., a regenerative ingredient company, produces vertically integrated supply chain products in Canada, the United States, Mexico, China, France, Turkey, and internationally. It operates through two segments: Disruptive Agriculture and Rudimentary Ingredients, and Consumer Packaged Goods. The Disruptive Agriculture and Rudimentary Ingredients segment engages in the provisioning of discrete genetics, origination, purchasing, grading, processing, and sale of regeneratively grown grain; and origination, purchase, and sale of bespoke ingredients products. The Consumer Packaged Goods segment formulates, manufactures, sells, distributes, and markets proprietary consumer product formulations in owned brands; and focuses on manufacturing and distribution for private-labeled retail owned brands. Above Food Ingredients Inc. is based in Regina, Canada.
ABVE (Above Food Ingredients Inc. Common Stock) trades in the Consumer Defensive sector, specifically Packaged Foods, with a market capitalization of approximately $26.3M, a beta of -0.25 versus the broader market, a 52-week range of 0.317-6.56, average daily share volume of 3.0M, a public-listing history dating back to 2024, approximately 2 full-time employees. These structural characteristics shape how ABVE stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.
A beta of -0.25 indicates ABVE has historically moved less than the broader market, dampening realized volatility and producing tighter expected-move bands per unit of dollar exposure.
What is a strangle on ABVE?
A long strangle buys an OTM call and an OTM put at offset strikes, cheaper than a straddle but requiring a larger underlying move to profit since both wings start out-of-the-money.
Current ABVE snapshot
As of May 15, 2026, spot at $0.51, ATM IV 273.30%, IV rank 57.69%, expected move 78.35%. The strangle on ABVE below is built from the same end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 34-day expiry.
Why this strangle structure on ABVE specifically: ABVE IV at 273.30% is mid-range versus its 1-year history, so strategy selection should anchor more to the directional thesis than to the IV regime, with a market-implied 1-standard-deviation move of approximately 78.35% (roughly $0.40 on the underlying). The 34-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated ABVE expiries trade a higher absolute premium for lower per-day decay. Position sizing on ABVE should anchor to the underlying notional of $0.51 per share and to the trader's directional view on ABVE stock.
ABVE strangle setup
The ABVE strangle below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With ABVE near $0.51, the first option leg uses a $0.54 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed ABVE chain at a 34-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 ABVE shares for the stock leg in covered calls and collars).
| Action | Type | Strike / Basis | Premium (est) |
|---|---|---|---|
| Buy 1 | Call | $0.54 | N/A |
| Buy 1 | Put | $0.48 | N/A |
ABVE strangle risk and reward
- Net Premium / Debit
- N/A
- Max Profit (per contract)
- Unbounded
- Max Loss (per contract)
- Unbounded
- Breakeven(s)
- None on modeled curve
- Risk / Reward Ratio
- N/A
Upside max profit is unbounded; downside max profit is bounded at the put strike minus the combined debit (reached at zero). Max loss equals the combined debit times 100 (reached anywhere between the two OTM strikes). Two breakevens at call-strike plus debit and put-strike minus debit.
ABVE strangle payoff curve
Modeled P&L at expiration across a range of underlying prices for the strangle on ABVE. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.
When traders use strangle on ABVE
Strangles on ABVE are the cheaper cousin of the straddle - traders use them when they want a large directional move but are willing to give up the inner-strike sensitivity in exchange for a lower up-front debit on the ABVE chain.
ABVE thesis for this strangle
The market-implied 1-standard-deviation range for ABVE extends from approximately $0.11 on the downside to $0.91 on the upside. A ABVE long strangle is the OTM cousin of the straddle: lower up-front cost but the underlying has to travel further past either OTM strike before the position turns profitable at expiration. Current ABVE IV rank near 57.69% is mid-range against its 1-year distribution, so the IV signal is neutral; the strangle thesis on ABVE should anchor more to the directional view and the expected-move geometry. As a Consumer Defensive name, ABVE options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to ABVE-specific events.
ABVE strangle positions are structurally neutral / high-volatility (long premium, OTM); the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. ABVE positions also carry Consumer Defensive sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move ABVE alongside the broader basket even when ABVE-specific fundamentals are unchanged. Always rebuild the position from current ABVE chain quotes before placing a trade.
Frequently asked questions
- What is a strangle on ABVE?
- A strangle on ABVE is the strangle strategy applied to ABVE (stock). The strategy is structurally neutral / high-volatility (long premium, OTM): A long strangle buys an OTM call and an OTM put at offset strikes, cheaper than a straddle but requiring a larger underlying move to profit since both wings start out-of-the-money. With ABVE stock trading near $0.51, the strikes shown on this page are snapped to the nearest listed ABVE chain strike and the premiums come straight from the end-of-day bid/ask midpoint.
- How are ABVE strangle max profit and max loss calculated?
- Upside max profit is unbounded; downside max profit is bounded at the put strike minus the combined debit (reached at zero). Max loss equals the combined debit times 100 (reached anywhere between the two OTM strikes). Two breakevens at call-strike plus debit and put-strike minus debit. For the ABVE strangle priced from the end-of-day chain at a 30-day expiry (ATM IV 273.30%), the computed maximum profit is unbounded per contract and the computed maximum loss is unbounded per contract. Live intraday quotes will differ as the chain moves through the trading session.
- What is the breakeven for a ABVE strangle?
- The breakeven for the ABVE strangle priced on this page is no defined breakeven on the modeled curve at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current ABVE market-implied 1-standard-deviation expected move is approximately 78.35%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
- When should you consider a strangle on ABVE?
- Strangles on ABVE are the cheaper cousin of the straddle - traders use them when they want a large directional move but are willing to give up the inner-strike sensitivity in exchange for a lower up-front debit on the ABVE chain.
- How does current ABVE implied volatility affect this strangle?
- ABVE ATM IV is at 273.30% with IV rank near 57.69%, which is mid-range against its 1-year history. Strategy selection depends more on directional thesis and expected move than on a strong IV signal.